DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

POVIDONE

Search structure
Synonyms:
1-vinyl-2-pyrrolidinone polymer
E-1201
INS-1201
INS NO.1201
K30
K90)
Kollidon 25, 30, 12pf, 17pf, 90f
NSC-114022
NSC-142693
Plasdone
Polyvidone
Polyvinylpyrrolidone
Polyvinylpyrrolidone-(1201)
Polyvinylpyrrolidone (k25
Polyvinylpyrrolidone [k25, k30, k90]
Povidone
Povidones
Povidone, unspecified
Povidonum
Vinisil
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: FZ989GH94E

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Blepharitis 2 D001762 ClinicalTrials
Thymoma 1 D013945 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 9003-39-8
ChEMBL CHEMBL2108139
FDA SRS FZ989GH94E
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70